Fax: (770) 488-4639.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Supplement
You have full text access to this OnlineOpen article
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods†‡§
Article first published online: 3 NOV 2008
DOI: 10.1002/cncr.23758
Published 2008 by the American Cancer Society
Issue
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Cancer
Supplement: Assessing the Burden of HPV-Associated Cancers in the United States
Volume 113, Issue Supplement 10, pages 2841–2854, 15 November 2008
Additional Information
How to Cite
Watson, M., Saraiya, M., Ahmed, F., Cardinez, C. J., Reichman, M. E., Weir, H. K. and Richards, T. B. (2008), Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methods. Cancer, 113: 2841–2854. doi: 10.1002/cncr.23758
- †
The maps in Figure ‖ were developed by James Cucinelli (IMS, Inc.) and Dave Stinchcomb (National Cancer Institute) based on the micromaps design (Carr and Pierson, 1996). Fonda Martin provided additional graphics assistance.
- ‡
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
- §
This is a US government work and, as such, is in the public domain in the United States of America.
Publication History
- Issue published online: 3 NOV 2008
- Article first published online: 3 NOV 2008
- Manuscript Accepted: 7 MAY 2008
- Manuscript Revised: 6 MAY 2008
- Manuscript Received: 14 APR 2008
Funded by
- Cooperative Agreement. Grant Number: U50 DP424071-04
- Centers for Disease Control and Prevention (CDC)
- Abstract
- Article
- References
- Cited By
Keywords:
- methods;
- human papillomavirus;
- cancer;
- surveillance
Abstract
Increased attention to human papillomavirus (HPV)-associated cancers in light of the recent release of an HPV vaccine, as well as increased availability of cancer registry data that now include reporting from a large proportion of the US population, prompted the current assessment of HPV-associated cancers. This article describes methods used to assess the burden of HPV-associated cervical, vulvar, vaginal, penile, anal, and oral cavity/oropharyngeal cancers in the United States during 1998 through 2003 using cancer registry data, and it provides a brief overview of the epidemiology of these cancers. Cancer 2008;113(10 suppl):2841–54. Published 2008 by the American Cancer Society.